Propionic Acidemia Therapeutic Market Size
Market Size in USD Mn
CAGR8.00%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 8.00% |
| Market Concentration | Medium |
| Major Players | HemoShear Therapeutics, LogicBio Therapeutics, Roche, Astellas Pharma, Moderna Therapeutics and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Propionic Acidemia Therapeutic Market Analysis
The propionic acidemia therapeutic market is estimated to be valued at USD 648.7 Mn in 2025 and is expected to reach USD 1111.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2032. Increase in research and development activities for developing newer treatments for propionic acidemia is a major factor anticipated to drive market growth. Several pipeline drugs are under development which upon approval will provide novel treatment options and boost market revenues.